Theriva Biologics, Inc. (TOVX)
0.24
0.00 (0.00%)
USD |
NYAM |
Aug 24, 16:00
0.24
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Total Liabilities (Quarterly) : 22.67M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.67M |
| March 31, 2026 | 22.85M |
| December 31, 2025 | 28.30M |
| September 30, 2025 | 24.10M |
| June 30, 2025 | 25.21M |
| March 31, 2025 | 16.66M |
| December 31, 2024 | 20.67M |
| September 30, 2024 | 15.47M |
| June 30, 2024 | 14.74M |
| March 31, 2024 | 14.61M |
| December 31, 2023 | 20.51M |
| September 30, 2023 | 17.66M |
| June 30, 2023 | 17.70M |
| March 31, 2023 | 17.30M |
| December 31, 2022 | 20.47M |
| September 30, 2022 | 20.55M |
| June 30, 2022 | 20.66M |
| March 31, 2022 | 20.97M |
| December 31, 2021 | 4.957M |
| September 30, 2021 | 4.561M |
| June 30, 2021 | 3.524M |
| March 31, 2021 | 2.23M |
| December 31, 2020 | 3.152M |
| September 30, 2020 | 3.271M |
| June 30, 2020 | 3.763M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.281M |
| December 31, 2019 | 5.748M |
| September 30, 2019 | 6.172M |
| June 30, 2019 | 4.412M |
| March 31, 2019 | 3.624M |
| December 31, 2018 | 3.686M |
| September 30, 2018 | 4.243M |
| June 30, 2018 | 4.672M |
| March 31, 2018 | 5.464M |
| December 31, 2017 | 10.20M |
| September 30, 2017 | 17.95M |
| June 30, 2017 | 12.78M |
| March 31, 2017 | 16.96M |
| December 31, 2016 | 20.25M |
| September 30, 2016 | 14.22M |
| June 30, 2016 | 15.40M |
| March 31, 2016 | 17.77M |
| December 31, 2015 | 15.84M |
| September 30, 2015 | 17.50M |
| June 30, 2015 | 25.50M |
| March 31, 2015 | 15.34M |
| December 31, 2014 | 9.588M |
| September 30, 2014 | 0.984M |
| June 30, 2014 | 1.232M |
| March 31, 2014 | 0.773M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 446.97M |
| Nkarta, Inc. | 89.91M |
| Unicycive Therapeutics, Inc. | 18.76M |
| OnKure Therapeutics, Inc. | 7.245M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.86M |
| Shareholders Equity (Quarterly) | 12.19M |
| Debt to Equity Ratio | 0.2915 |
| Current Ratio | 1.129 |
| Net Debt Paydown Yield | -1.22% |